For example, the answer rate was 100.0% for cases and controls when asked about their childs APAP use in conjunction with vaccines, 83.1% and 85% for cases and controls, respectively, when asked about their childs APAP use between 12 and 18 months of age, and 59.0% and 72.5% for cases and controls, respectively, when asked about their childs exposure to ibuprofen between 12 and 18 months of age
10.1016/j.bpc.2020.106457 94 JohnstonH
[3] In other words, the R3 change selectively degrades one interaction (binding-protein capture) without abolishing the other (receptor signaling)
Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)
As indicated, despite the tumor-promoting effects of many growth factors and peptides (Gwyer et al., 2019